Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 30

1.

Inflammatory bowel disease and cancer: The role of inflammation, immunosuppression, and cancer treatment.

Axelrad JE, Lichtiger S, Yajnik V.

World J Gastroenterol. 2016 May 28;22(20):4794-801. doi: 10.3748/wjg.v22.i20.4794. Review.

2.

Clostridium difficile Infection: A Rarity in Patients Receiving Chronic Antibiotic Treatment for Crohn's Disease.

Roy A, Lichtiger S.

Inflamm Bowel Dis. 2016 Mar;22(3):648-53. doi: 10.1097/MIB.0000000000000641.

3.

Human Placenta-derived Cells (PDA-001) for the Treatment of Moderate-to-severe Crohn's Disease: A Phase 1b/2a Study.

Melmed GY, Pandak WM, Casey K, Abraham B, Valentine J, Schwartz D, Awais D, Bassan I, Lichtiger S, Sands B, Hanauer S, Richards R, Oikonomou I, Parekh N, Targan S, Johnson K, Hariri R, Fischkoff S.

Inflamm Bowel Dis. 2015 Aug;21(8):1809-16. doi: 10.1097/MIB.0000000000000441.

PMID:
25985246
4.

Validation of endoscopic activity scores in patients with Crohn's disease based on a post hoc analysis of data from SONIC.

Ferrante M, Colombel JF, Sandborn WJ, Reinisch W, Mantzaris GJ, Kornbluth A, Rachmilewitz D, Lichtiger S, D'Haens GR, van der Woude CJ, Danese S, Diamond RH, Oortwijn AF, Tang KL, Miller M, Cornillie F, Rutgeerts PJ; International Organization for the Study of Inflammatory Bowel Diseases.

Gastroenterology. 2013 Nov;145(5):978-986.e5. doi: 10.1053/j.gastro.2013.08.010. Epub 2013 Aug 14.

PMID:
23954314
5.

Risk of extraintestinal solid cancer with anti-TNF therapy in adults with inflammatory bowel disease: review of the literature.

Hudesman D, Lichtiger S, Sands B.

Inflamm Bowel Dis. 2013 Mar;19(3):644-9. doi: 10.1097/MIB.0b013e318280ebbd. Review.

PMID:
23314243
6.

Ustekinumab induction and maintenance therapy in refractory Crohn's disease.

Sandborn WJ, Gasink C, Gao LL, Blank MA, Johanns J, Guzzo C, Sands BE, Hanauer SB, Targan S, Rutgeerts P, Ghosh S, de Villiers WJ, Panaccione R, Greenberg G, Schreiber S, Lichtiger S, Feagan BG; CERTIFI Study Group.

N Engl J Med. 2012 Oct 18;367(16):1519-28. doi: 10.1056/NEJMoa1203572.

7.

The effect of intravenous cyclosporine on rates of colonic surgery in hospitalized patients with severe Crohn's colitis.

Lazarev M, Present DH, Lichtiger S, Kornbluth A, Marion J, Chapman M, Ullman TA.

J Clin Gastroenterol. 2012 Oct;46(9):764-7. doi: 10.1097/MCG.0b013e31824e14a8.

PMID:
22751334
8.

Evaluation of 22 genetic variants with Crohn's disease risk in the Ashkenazi Jewish population: a case-control study.

Peter I, Mitchell AA, Ozelius L, Erazo M, Hu J, Doheny D, Abreu MT, Present DH, Ullman T, Benkov K, Korelitz BI, Mayer L, Desnick RJ; New York Crohn's Disease Working Group.

BMC Med Genet. 2011 May 6;12:63. doi: 10.1186/1471-2350-12-63.

9.

The CHOICE trial: adalimumab demonstrates safety, fistula healing, improved quality of life and increased work productivity in patients with Crohn's disease who failed prior infliximab therapy.

Lichtiger S, Binion DG, Wolf DC, Present DH, Bensimon AG, Wu E, Yu AP, Cardoso AT, Chao J, Mulani PM, Lomax KG, Kent JD.

Aliment Pharmacol Ther. 2010 Nov;32(10):1228-39. doi: 10.1111/j.1365-2036.2010.04466.x. Epub 2010 Sep 28.

10.

Infliximab, azathioprine, or combination therapy for Crohn's disease.

Colombel JF, Sandborn WJ, Reinisch W, Mantzaris GJ, Kornbluth A, Rachmilewitz D, Lichtiger S, D'Haens G, Diamond RH, Broussard DL, Tang KL, van der Woude CJ, Rutgeerts P; SONIC Study Group.

N Engl J Med. 2010 Apr 15;362(15):1383-95. doi: 10.1056/NEJMoa0904492.

11.

Early clinical experience with adalimumab in treatment of inflammatory bowel disease with infliximab-treated and naïve patients.

Swaminath A, Ullman T, Rosen M, Mayer L, Lichtiger S, Abreu MT.

Aliment Pharmacol Ther. 2009 Feb 1;29(3):273-8. doi: 10.1111/j.1365-2036.2008.03878.x. Epub 2008 Oct 22.

12.

Cyclosporine and infliximab as rescue therapy for each other in patients with steroid-refractory ulcerative colitis.

Maser EA, Deconda D, Lichtiger S, Ullman T, Present DH, Kornbluth A.

Clin Gastroenterol Hepatol. 2008 Oct;6(10):1112-6. doi: 10.1016/j.cgh.2008.04.035.

PMID:
18928936
13.

Treatment of choice for acute severe steroid-refractory ulcerative colitis is cyclosporine.

Lichtiger S.

Inflamm Bowel Dis. 2009 Jan;15(1):141-2. doi: 10.1002/ibd.20363. Review. No abstract available.

PMID:
18266232
14.

Adverse events associated with the use of cyclosporine in patients with inflammatory bowel disease.

Sternthal MB, Murphy SJ, George J, Kornbluth A, Lichtiger S, Present DH.

Am J Gastroenterol. 2008 Apr;103(4):937-43. doi: 10.1111/j.1572-0241.2007.01718.x. Epub 2008 Jan 2.

PMID:
18177449
15.

Dilation of colonic strictures by intralesional injection of infliximab in patients with Crohn's colitis.

Swaminath A, Lichtiger S.

Inflamm Bowel Dis. 2008 Feb;14(2):213-6. Review.

PMID:
18022870
16.

Mucosal dysplasia in ileal pelvic pouches after restorative proctocolectomy.

Nilubol N, Scherl E, Bub DS, Gorfine SR, Marion J, Harris MT, Kornbluth A, Lichtiger S, Rubin P, George J, Chapman M, Harpaz N, Present D, Bauer JJ.

Dis Colon Rectum. 2007 Jun;50(6):825-31.

PMID:
17429711
17.

Do guidelines matter? Implementation of the ACG and AGA osteoporosis screening guidelines in inflammatory bowel disease (IBD) patients who meet the guidelines' criteria.

Kornbluth A, Hayes M, Feldman S, Hunt M, Fried-Boxt E, Lichtiger S, Legnani P, George J, Young J.

Am J Gastroenterol. 2006 Jul;101(7):1546-50.

PMID:
16863559
18.

Case report: lymphoma arising in an ileal pouch anal anastomosis after immunomodulatory therapy for inflammatory bowel disease.

Schwartz LK, Kim MK, Coleman M, Lichtiger S, Chadburn A, Scherl E.

Clin Gastroenterol Hepatol. 2006 Aug;4(8):1030-4. Epub 2006 Jul 18.

PMID:
16854631
19.

The risk of retention of the capsule endoscope in patients with known or suspected Crohn's disease.

Cheifetz AS, Kornbluth AA, Legnani P, Schmelkin I, Brown A, Lichtiger S, Lewis BS.

Am J Gastroenterol. 2006 Oct;101(10):2218-22. Epub 2006 Jul 18.

PMID:
16848804
20.

Ulcerative colitis and sarcoidosis.

Nilubol N, Taub PJ, Venturero M, Lichtiger S, Bauer JJ.

Mt Sinai J Med. 2001 Nov;68(6):400-2.

PMID:
11687869
Items per page

Supplemental Content

Loading ...
Write to the Help Desk